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ARTICLE
Whole genome sequencing in the Middle Eastern
Qatari population identifies genetic associations
with 45 clinically relevant traits
Gaurav Thareja 1,19, Yasser Al-Sarraj 2,3,19, Aziz Belkadi 1,4, Maryam Almotawa2,3, The Qatar Genome
Program Research (QGPR) Consortium*, Karsten Suhre 1,4,20✉ & Omar M. E. Albagha 2,3,5,20✉
Clinical laboratory tests play a pivotal role in medical decision making, but little is known
about their genetic variability between populations. We report a genome-wide association
study with 45 clinically relevant traits from the population of Qatar using a whole genome
sequencing approach in a discovery set of 6218 individuals and replication in 7768 subjects.
Trait heritability is more similar between Qatari and European populations (r= 0.81) than
with Africans (r= 0.44). We identify 281 distinct variant-trait-associations at genome wide
significance that replicate known associations. Allele frequencies for replicated loci show
higher correlations with European (r= 0.94) than with African (r= 0.85) or Japanese (r=
0.80) populations. We find differences in linkage disequilibrium patterns and in effect sizes of
the replicated loci compared to previous reports. We also report 17 novel and Qatari-
predominate signals providing insights into the biological pathways regulating these traits.
We observe that European-derived polygenic scores (PGS) have reduced predictive perfor-
mance in the Qatari population which could have implications for the translation of PGS
between populations and their future application in precision medicine.
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Genome-wide association studies (GWAS) have providednew insights into the genetic determinants of manyclinically relevant traits and identified thousands of dis-
ease- or trait-associated genetic variants1,2. However, most of the
published GWAS studies performed to-date are from European,
or East Asian populations3,4. Middle Eastern populations are
under-represented. Also, all GWAS conducted so far used gen-
otyping arrays imputed on genome sequencing data from studies
in which only few, if any, Middle Eastern genomes were present
and therefore miss all population-specific signals. Large-scale
GWAS of many traits and complex diseases in Africans and
Asians indicated differences in the genetic architecture between
populations, but included few, if any, study participants from
Arab ethnicities. In addition, many trait-associated variants show
differences in allele frequencies and effect sizes across popula-
tions5–7 which may complicate the derivation of polygenic scores.
Recent studies have shown that polygenic risk scores derived
from studies in European populations have lower predictive
performance when applied to non-European populations8, pro-
viding strong argument for conducting GWAS in non-European
populations that are less represented in previously published
studies.
Here, we report the first comprehensive GWAS of 45 clinically
relevant traits in a Middle Eastern population using a whole
genome sequencing approach. We unveil differences in herit-
ability of certain life-style related traits between populations,
investigate differences in the genetic architecture of replicating
loci, assess the performance of European-derived polygenic scores
in Qatari population, and report novel trait associations that are
predominant to the Middle Eastern population of Qatar.
Results
The qatar genome program (QGP). The QGP is a population-
based study designed to perform whole genome sequencing of the
Qatar Biobank (QBB) participants9 with the aim to gain insights
into the population structure and the genetic architecture of
clinically relevant phenotypes in the Middle Eastern Qatari
population. The present study is based on whole genome
sequence data from 6218 participants of QBB and further repli-
cation in 7768 subjects from the second batch of QBB data. We
performed a comprehensive heritability and genome-wide asso-
ciation study for 45 clinically relevant traits in the Middle Eastern
population of Qatar. The investigated traits cover the following
categories (Table 1): anthropometry (N= 3), electrolytes (N= 7),
measures of enzyme activity or abundance (N= 5), blood
coagulation-related traits (N= 4), blood cell composition (N= 9),
lipid traits (N= 4), and other clinically-relevant biochemistry
measurements (N= 13). A detailed description of the study
population and phenotype assessment is provided in the methods
section, Supplementary Data 1 and Supplementary Table 1. A
pairwise correlation analysis of the analyzed traits (Supplemen-
tary Fig. 1) revealed correlations between related traits, such as
the liver-derived enzymes ALT, AST, ALP, and GGT (abbrevia-
tions are given in Table 1), traits related to hemoglobin and red
blood cells (Hb, Ht, MCV, MCH, MCHC, and Frtn), and traits
related to iron metabolism, such as Fe, TIBC, Hb, and Ht.
Heritability of clinically relevant traits in the Qatari popula-
tion. The proportion of variation that can be attributed to genetic
factors (heritability) has been investigated for many clinically-
relevant traits, but mainly in populations of European
descent10,11. A recent study in the Ugandan population of Africa
showed marked differences in heritability estimates for many
complex traits compared to European populations6. For example,
estimates of heritability for body height in Ugandan populations
was significantly lower (49%) than those from European popu-
lations (77%) suggesting differences in genetic loci and/or pro-
portion of environmental contribution. The heritability of most
traits in Middle Eastern populations remains undetermined. We
therefore performed a comprehensive assessment of the herit-
ability (h2) of the 45 traits in the QGP data. We found that h2
Table 1 Summary of clinically-relevant quantitative traits
investigated in this study.
Trait Abbreviation n h2 GWS loci
Known New
Anthropometric
Sitting height S-Height 6034 0.52 1 0
Height Height 6044 0.59 1 0
Body mass index BMI 6039 0.31 2 0
Electrolytes
Calcium Ca 6020 0.22 1 0
Chloride Cl 6018 0.21 0 0
Iron Fe 6010 0.13 1 0
Magnesium Mg 5996 0.30 3 1
Potassium K 6017 0.19 0 0
Sodium Na 6018 0.16 0 0
Bicarbonate HCO3 6017 0.24 0 0
Enzymes
Alkaline phosphatase ALP 6012 0.41 7 0
Alanine
aminotransferase
ALT 6018 0.23 1 0
Aspartate
aminotransferase
AST 6018 0.24 0 0
Creatine kinase CK 5344 0.35 4 0
Gamma glutamyl
transferase




APTT 5988 0.43 24 0
Prothrombin time PT 5989 0.48 23 1
International
normalization ratio
INR 5987 0.35 17 1
Fibrinogen Fbg 5984 0.35 4 0
Blood Cells
White blood cell count WBC 6007 0.48 42 5




MCHC 6007 0.44 4 0
Mean corpuscular
hemoglobin
MCH 6007 0.50 13 0
Mean corpuscular
volume
MCV 6007 0.51 10 0
Platelet count Plt 5935 0.46 4 0
Mean platelet volume MPV 6006 0.57 11 0
Hematocrit Ht 6007 0.21 0 0
Hemoglobin Hb 6006 0.23 0 0
Lipids
Total cholesterol TCH 6017 0.22 6 0
High density lipoprotein
cholesterol
HDL-C 6013 0.41 6 0
Low density lipoprotein
cholesterol
LDL-C 5972 0.21 6 0
Triglycerides TG 6017 0.31 8 1
Other biochemical
Total protein TPrt 6017 0.32 0 0
Albumin Alb 6018 0.27 0 0
Ferritin Frtn 5947 0.16 0 0
C-peptide C-Pep 5925 0.19 0 0
Pro B-type natriuretic
peptide
proBNP 5516 0.25 4 0
Total iron binding
capacity
TIBC 6010 0.31 17 0
Unsaturated iron
binding capacity
UIBC 5956 0.23 9 0
Total bilirubin Tbil 6018 0.39 21 3
Uric acid UA 6013 0.31 6 1
Folate Flt 5944 0.33 3 0
Serum creatinine sCr 6018 0.32 1 0
Homocysteine Hcyst 5727 0.30 5 3
Vitamin B12 Vit-B12 5865 0.29 7 1
n sample size, h2 heritability, GWS genome-wide significant.
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estimates ranged from 13% for serum iron levels (Fe) to 59% for
body height (Table 1). We compared our findings with herit-
ability estimates from European10,11 and African populations6.
Overall, the correlation of h2 between European and Middle
Eastern populations was higher (r= 0.81) compared to the cor-
relation between African and Middle Eastern populations (r=
0.44; Supplementary Fig. 2). For several traits, h2 estimates in the
Middle Eastern population were significantly different from
European and African populations (Fig. 1, Supplementary
Tables 2 and 3). For example, estimates of h2 for height in QGP
(59%) was lower than in European (77%; P= 6.0 × 10−7) but not
significantly different from African populations (49%, P= 0.09).
Similarly, heritability for BMI in QGP (31%) was lower than in
Europeans; namely Sardinia (43%; P= 8.8 × 10−4) and Iceland
(42%; P= 2.3 × 10−3). Interestingly, h2 for the liver enzyme GGT
in QGP data (35%) was similar to the European populations
(34%; P= 0.78) but significantly higher than in African popula-
tions (10%, P= 5.8 × 10−7). In contrast, estimates of heritability
for cholesterol in QGP data (TCH= 22%; LDL-C= 21%) was
significantly lower than values from European (TCH= 37%; P=
3.2 × 10−5, LDL-C= 38%; P= 2.4 × 10−6) or African (TCH=
53%; P= 1.1 × 10−7, LDL-C= 54%; P= 1.6 × 10−8) populations.
Genome-wide association analysis of 45 complex traits. We
performed genome-wide association analyses of 45 clinically-
relevant quantitative traits using whole genome sequencing data
for 6218 individuals from the QGP study. We focused on com-
mon and low frequency variants (MAF > 1%; N= 7,880,618)
using linear mixed models correcting for age, sex, population
principal components and relatedness (see methods). The geno-
mic inflation factor (λGC) ranged between 0.99 and 1.13 (mean ±
S.D; 1.03 ± 0.03; Supplementary Table 4). Most analyzed traits (37
out of the 45 traits) showed very little inflation (λGC ≤ 1.04).
Considerable inflation was only detected for traits that are well-
known to have large polygenic architecture such as adult height
(λGC= 1.13) and BMI (λGC= 1.09). Manhattan and quantile-
quantile plots for the studied traits are presented in Supple-
mentary Data 2.
Figure 2 shows a Manhattan plot comprising association data
for all 45 studied traits. We identified 301 distinct variant-trait-
associations that reached a genome wide significance level of P <
5.0 × 10−8 (Table 1 and Supplementary Data 3). For each trait, a
distinct signal was defined as the variant with the lowest P value
and not in linkage disequilibrium (LD; r2 < 0.1) with any other
variant within a window of 10Mb. Of the 301 identified genetic
signals, 281 were located within ±500 kb of a previously reported
variant for the same trait. We replicated many loci that are known
to have consistent association in studies across various population
ancestry2. Examples include the SLC2A9 locus for uric acid
(rs13129697; P= 2.8 × 10−41), the UGT1A4 locus for total
bilirubin (Tbil; rs887829; P= 3.5 × 10−251) and the APOE locus
Fig. 1 Heritability estimates of 45 clinically-relevant traits. Heritability estimates of 45 clinically-relevant traits in the Qatar Genome Program cohort
(QGP; red markers) compared to estimates from Sardinian (green marker) and Ugandan (blue markers) populations. The heritability estimates in QGP was
adjusted for age, gender, the first four population principal components and relatedness. The heritability estimates for several traits in QGP were
significantly different from European10 and African6 Populations (Supplementary Table 2). Refer to Table 1 for trait abbreviations. Data are presented as
mean ± SEM.
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for low density lipoprotein-cholesterol (LDL-C; rs7412; P= 6.3 ×
10−29). Of the 281 genome-wide significant variant-trait associa-
tions, 51 were observed for the same SNP as reported in the
PhenoScanner12. For these SNPs it was possible to assess the
direction of association (for variants with available effect-allele;
N= 43) and all showed directionality of association consistent
with previous reports. We also observed multiple distinct signals
for many loci (Supplementary Data 3). For example, 17 distinct
genome-wide significant signals were observed for total bilirubin
(Tbil) in a 515 kb region on chromosome 2 (Fig. 3a). Notably, this
Tbil locus harbors the complex UGT1A gene locus that encodes
nine enzymes which differ in their N-termini as a result of
splicing nine unique substrate-recognizing first exons into four
shared exons. These enzymes are involved in transforming
lipophilic substrates, such as bilirubin, into water soluble
metabolites. Another example was prothrombin time (PT) for
which 20 distinct genome-wide significant signals were detected
in a 615 kb region on chromosome 13 (Fig. 3b) which harbors
two coagulation factor genes: F7 and F10. We investigated
whether differences in linkage disequilibrium (LD) patterns
between QGP data and other populations can account for
differences in signal patterns. LD analysis of the Tbil and PT loci
shows marked differences in LD patterns and allele frequencies
between the European, East Asian and QGP populations (Fig. 3).
For example, nine of the 17 distinct genome-wide significant
signals from the Tbil locus are either monomorphic (N= 6) or
very rare (MAF < 0.3%; N= 3) in the East Asian population
whereas only two of the variants are very rare in Europeans.
To assess to which degree we replicate the effect sizes of known
signals in QGP, we compared our results to previously published
work focusing on a single large comprehensive GWAS of similar
traits from the Biobank Japan project (BBJ)7 as a reference. We
selected this study because it represents the largest and most
comprehensive published GWAS of similar traits, and because the
traits in the BBJ study were transformed similarly to our analysis,
which allows a direct comparison of variant-level effect sizes for
the identified loci (Z-Score or rank-based inverse normal
transformation). In the BBJ study, Kanai et al.7 performed a
GWAS of 58 clinically-relevant traits in study participants of East
Asian descent. Of the 45 traits analyzed in the present study, 28
traits overlapped with those analyzed by the BBJ project. For
these traits, the BBJ study identified a total of 907 trait-variant
associations which include known loci from previous studies in
various populations (N= 575; mainly Europeans) as well as new
loci identified in the Japanese population (N= 332). Of the 907
association, we could evaluate 898 in QGP: 659 for which the
same genetic variant was available in our data set (designated as
group A variants) and 239 for which at least one proxy variant
within 1Mb in our data was in strong LD (r2 ≥ 0.8; N= 149;
designated as group B variants) or exhibited some degree of LD
(r2= 0.1 to 0.8; N= 90; designated as group C variants) with the
variant reported in BBJ (Table 2 and Supplementary Data 4). For
9 variants, no suitable proxy was found in our dataset.
The genetic architecture for many traits can vary between
populations. Differences in allele frequency and /or effect size for
many trait-associated variants are known to exist between
populations5. Since polygenic risk scores estimated from one
population may not be precisely applicable to other populations,
we assessed replication, allele frequency and effect size for group
A variants in QGP data. We found 29 loci that replicated at a
Bonferroni-corrected significance threshold of P < 5.6 × 10−5
(0.05/898). All had consistent direction of effect. Comparison of
effect size for the replicated loci showed a significant trend for
higher effect sizes in QGP compared to BBJ (regression slope=
1.21; 95% CI= 1.01–1.42; P= 3.2 × 10−12; Fig. 4). Of the 29
replicated loci, 17 showed an effect size that is 20% larger in our
data compared to BBJ. Comparison of allele frequencies for
replicated loci shows higher correlation with European (r= 0.94)
compared to African (r= 0.85) or Japanese (r= 0.80) populations
(Fig. 4). Further analysis using colocalization testing (see
methods) showed that out of the 29 replicated loci, 22 share
the same association signal, whereas 7 had distinct signals
between QGP and BBJ; highlighting differences in LD patterns
between the two populations (Supplementary Data 5).
When using a nominal significance threshold (P < 0.05), 180 of
the 659 group A variants show nominal evidence of replication
and all but seven of these have consistent direction of effect with
the variant reported in BBJ. Analysis of these loci revealed
significant differences in the distribution of effect size compared
to BBJ data (Supplementary Fig. 3). We found a significantly
larger number of loci with an effect size (Beta) between 0.05 – 0.1
in our data (N= 80) compared to BBJ (N= 51; P= 6 × 10−4).
Conversely, a larger number of loci with small effects (Beta <
0.05) was observed in BBJ (n= 97) compared to our data (n= 60;
P= 2.7 × 10−5) but no significant difference was found for loci
with an effect size > 0.1 (P > 0.05). Comparison of allele
frequencies for these loci also shows higher correlation with
European (r= 0.94) compared to African (r= 0.75) or Japanese
population (r= 0.70). Colocalization analysis showed that 16 out
of the 180 loci (8.9%) had distinct signals between QGP and BBJ
(Supplementary Data 5).
A number of group B (11 out of 149) and group C variants (2
out of 90) showed evidence of replication for the same trait after
correction for multiple testing (Table 2). In addition, a number of
loci that did not show nominal replication (P > 0.05) contained a
signal within ±500 kb with significant P-values for the same trait
(N= 115), after correction for multiple testing (Table 2). For
example, rs5030081 is associated with APTT in BBJ (P= 3.97 ×
10−49) but not in QGP (P= 0.21), however, a SNP (rs1042445)
located 63 kb upstream and not in LD with rs5030081 (r2= 0.05)
is significantly associated (P= 1.30 × 10−48) with the same trait
in QGP. In total, of the 898 variants identified in the BBJ study,
we identified 355 variants that showed evidence of replication
either directly, through a proxy, or located in a region previously
reported for the same trait.
Analysis of polygenic scores. To assess the translatability of
polygenic scores (PGS) derived from other populations to the
Qatari population, we assessed the predictive performance of PGS
Fig. 2 Manhattan plot of GWAS results from 45 clinically-relevant traits.
The chromosomal position of genetic variants (N= 7,880,618) is plotted
against –log10 (P). Analysis was performed using linear mixed models
correcting for age, sex, population principal components and relatedness.
The red horizontal line represents the threshold for genome-wide
significance (P < 5.0 × 10−8).
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for traits with available scoring data in the Polygenic Score Cat-
alog (http://www.pgscatalog.org). We focused our analysis on
PGS derived from European populations since our heritability
and allele frequency comparison showed higher correlation
between QGP and Europeans. In addition, robust data with
enough information to allow comparison with our data was
mainly available for European populations. The predictive per-
formance of PGS from 11 traits was tested on QGP data and
Fig. 3 Comparison of allele frequency and linkage disequilibrium patterns. Example of multiple distinct signals identified at loci associated with clinically-
relevant traits. a Regional association plots for total bilirubin (Tbil) locus on chromosome 2 and (b) the prothrombin time (PT) locus on chromosome 13.
The plots show chromosomal positions of SNPs plotted against –log10 (P). Multiple distinct signals are shown as red circles, blue lines represent
recombination rate. c–f Comparison of allele frequency and linkage disequilibrium for the distinct signals between QGP and European population (c and d)
or between QGP and East Asian populations (e and f) for the Tbil and PT loci. Linkage disequilibrium patterns between the distinct signals from QGP data
are shown below the red diagonal boxes and those from European (c, d) or East Asian (e, f) populations are shown above the diagonal red boxes. Grayed
areas indicate monomorphic SNPs. MAF indicates minor allele frequency from QGP, European (CEU) or East Asian (EAS) populations.
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results are presented in Fig. 5. All tested PGS showed lower
performance when applied to QGP data with an average per-
formance of 64.7% (SD= 15.8%) of that when applied to Eur-
opeans (Supplementary Table 5). The relative performance of the
PGS when applied to Qataris compared to Europeans ranged
from 40.5% for Height to 98.1% for Mean Platelet Volume.
Novel loci associated with traits. Variants located in regions not
previously reported for the trait and showing significant associa-
tion (P < 5.0 × 10−8; N= 20) in the discovery set were tested for
replication in an additional 7768 subjects from the second data
release of QBB. Eight of the 20 novel loci replicated at a Bonfer-
roni level (P < 0.05/20). Meta-analysis of discovery and replication
results are shown in Table 3. Most signals were driven by genetic
variants that were either monomorphic (N= 3) or with a minor
allele frequency that is three- to seven-fold lower (N= 5) than
what is observed in European population ancestries13. These
include novel loci for coagulation-related traits (PT, and INR),
blood cell traits (WBC) and other biochemical traits (Hcyst, and
Tbil). Regional association plots (RAP) for novel loci are shown in
Supplementary Data 6. For example, we identified a novel asso-
ciation with Homocysteine (Hcyst) on chromosome 21
(rs147242481) near the CSTB gene with a relatively large effect size
(beta= 0.36 standard deviation units per allele; P= 1.0 × 10−13).
CSTB is a member of the cystatin superfamily that encodes the
Cystatin B protein that functions as protease inhibitor. It has been
shown that Cystatin C, another member of cystatin superfamily, is
a determinant of serum levels of Hcyst14,15. We also identified a
novel locus associated with two related coagulation traits (PT and
INR) on chromosome 13 situated near LINC01070, a gene that
encodes a long noncoding RNA. Another novel association was
identified with serum total bilirubin (Tbil) near ARL4C gene.
Serum level of Tbil is routinely used to assess liver function and
studies have shown that ARL4C is highly expressed in primary
hepatocellular carcinoma tumors and its expression is associated
with poor prognosis16. We also identified four novel loci for white
blood cell count trait (Table 3). One of these loci is located near
NHLH1 and data from the international mouse phenotyping
consortium (https://www.mousephenotype.org) shows that het-
erozygous Nhlh1 knockout mice have decreased basophil white
blood cell number compared to wild type (P= 3.1 × 10−17; Sup-
plementary Fig. 4).
Table 2 Summary of replicated loci compared to Biobank
Japan data7.






P < 0.05 P <
5.6 × 10−5
Group A 180 29 87 267 659
Group B 45 11 16 61 149
Group C 15 2 12 27 90
Total 240 42 115 355 898
aGroup A refers to same variants as reported by Kanai et al7, Group B and C refer to proxy
variants in strong LD (r2≥ 0.8) or shows some degree of LD (r2= 0.1 to 0.8) with variants
reported by Biobank Japan project7, respectively.
bNumber of loci that did not show replication at P < 0.05 but a significant signal was found
within 500 kb for the same trait. P values obtained from GWAS analysis of QGP data using
linear mixed models adjusting for age, sex, population principal components and relatedness.
Fig. 4 Comparison of allele frequency and effect size for known loci. a The effect size (Beta) for loci showing replication after correction for multiple
testing in QGP (blue bars) compared to Biobank Japan project (BBJ7, orange bars). b Correlation of effect size for replicated loci between QGP and BBJ.
c Correlation of allele frequency for replicated loci between QGP and BBJ (r= 0.80), QGP and European (EUR; r= 0.94), or QGP and African (AFR; r=
0.85) populations. Dotted lines represent lines of best fit from regression analysis.
Fig. 5 Performance of European-derived polygenic scores in QGP.
Pearson’s correlation (R) between polygenic scores (PGS) and trait values
are shown for European populations (red) and Qatari population (blue).
Weighted PGS scores were based on those derived from European
population.
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Qatari- predominant loci associated with traits. Population-
specific signals have been identified for clinically relevant traits in
previous GWAS6,7 but the existence of such signals in the Middle
Eastern populations has not been studied. We identified 12,283
autosomal variants that are common (MAF > 5%) in QGP but
rare (MAF < 1%) in all other population ancestries reported by
1000 Genome project13. These variants were pruned based on LD
(r2 < 0.1; N= 4357; referred to as Qatari-predominant loci) and
their association with the clinical traits was investigated. For these
loci, we used Bonferroni-adjusted significance threshold of P <
1.15 × 10−5 correcting for the number of tested variants. Loci
showing significant association in the discovery set were tested in
the replication set to confirm their association. Meta-analysis of
discovery and replication results identified 9 Qatari-
predominantvariant-trait-associations (Table 3). All of these sig-
nals were located near genes that had been previously associated
with the same trait.
Discussion
We performed one of the largest GWAS using whole genome
sequence data to date (n > 6200) and the first comprehensive
GWAS of 45 clinically-relevant traits from a Middle Eastern
population. Heritability estimates for the studied traits in QGP
were generally correlated with previous estimates in other
populations. However, significant differences in heritability were
observed for some traits suggesting differences in the genetic
architecture resulting from population-specific past events such
as genetic drift and selection. In addition, variations in environ-
mental factors and their interaction with genetic factors could
explain the observed differences in heritability. For example, the
heritability of GGT, an enzyme used clinically to assess liver
function, was similar to that reported in European populations
but significantly higher than in African populations. This obser-
vation could be due to a larger contribution of environmental
factors explaining the phenotypic variations in GGT in African
populations. High prevalence of liver diseases such as cirrhosis
and Hepatitis B virus infection in sub-Saharan African popula-
tions17 indicating substantial contribution of environmental fac-
tors leading to lower heritability estimates. In addition,
heritability estimates for cholesterol (TCH and LDL-C) in our
data were significantly lower compared to values reported in
European or African populations suggesting higher contribution
of environmental influences such as diet and lifestyle. Consistent
with this, heritability estimates for BMI in Qatar was also lower
when compared to two European populations. The prevalence of
obesity in Qatar is among the highest in the world18 and this
obesity endemic caused (at least in part) by fat-rich diet and
lifestyle factors plausibly leading to lower heritability estimates of
BMI and cholesterol traits. However, technical variations in
measurements could also contribute to the differences in herit-
ability between the studies.
Our GWAS results replicated many loci that are known to have
consistent association in studies across various population
ancestry, highlighting shared components of genetic architecture
for the studied traits. Comparison of replicated loci identified
differences in both effect size and allele frequency of the asso-
ciated variants, emphasizing the importance of performing fur-
ther larger GWAS in the Middle Eastern populations to enable
accurate polygenic score determination. Indeed, European-
derived PGS had substantially reduced predictive performance
when applied to QGP data. For some traits, we identified multiple
distinct signals due to differences in LD patterns and/or differ-
ences in allele frequencies of the variants. Colocalization analysis
showed that about 9% of replicated loci across the investigated
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Since most previously published GWAS for these traits were
performed using genotyping arrays followed by imputation, it is
possible that some of the multiple distinct signals observed in our
data could be due to higher coverage of whole genome sequencing
as opposed to imputation with implication on fine mapping and
identification of functional variants.
Our GWAS also identified novel signals providing new insights
into the biological pathways regulating clinically relevant traits,
such as CSTB for Hcyst and NHLH1 for white blood cell count.
We observed that most of the novel loci were driven by
population-specific variants and the existence of Qatari-
predominant signals within known loci emphasizes the differ-
ences in genetic architecture of these traits between populations.
These findings provide strong arguments for performing larger
GWAS in the Middle Eastern region to further define the genetic
architecture of clinical traits and complex diseases with implica-
tion on future application in precision medicine. They also
underscore the potential of discovering novel signals at lower
sample sizes when using understudied populations, which may be
relevant to future investments when searching for new drug
targets.
In conclusion, we performed a comprehensive heritability
analyses and GWAS studies of 45 clinically-relevant traits for the
first time in a middle eastern population. We replicated many
previously known loci for these traits demonstrating shared
genetic components across populations. However, we identified
differences in linkage disequilibrium patterns, effect size and
allele frequency of associated signals. We showed that European-
derived PGS has reduced predictive performance when applied to
the Middle Eastern population of Qatar. We also identified 17
novel and Qatari-predominant signals across the studied traits
which were mostly driven by population-specific variants pro-
viding an argument for further larger genetic association studies
in Middle Eastern and other non-Caucasian populations to fur-
ther characterize the genetic architecture of clinical traits and
complex diseases.
Methods
Study subjects. The present study was performed on the QBB study participants.
QBB is an on-going longitudinal population-based study aiming to recruit
60,000 subjects from the Qatari population with follow up every 5 years9. Indivi-
duals are eligible to participate in the study if they are Qatari nationals or long-
term residents (≥15 years living in Qatar) aged 18 years and older. The study covers
extensive baseline sociodemographic data, clinical and behavioral phenotypic data,
biological samples, as well as clinical biomarkers. All QBB participants signed an
informed consent form prior to their participation; and the study was approved by
Hamad Medical Corporation Ethics Committee and QBB institutional review
board. Heritability and GWAS analyses were performed on data from the first QBB
data release (6218 QBB participants). Replication analyses were based on an
additional 7768 QBB participants from the second QBB data release.
Phenotype. All QBB participants attended an assessment session in which physical
measurements were collected and each participant filled a standardized ques-
tionnaire reporting information on lifestyle, diet, and medical history. Collected
physical measurements included anthropometry (sitting and standing height,
weight, and waist and hip circumference), body composition, grip strength, arterial
stiffness, blood pressure, electrocardiogram data, respiratory function and cardi-
orespiratory fitness. Additional phenotypes were also collected, such as 3D carotid
ultrasound, full body dual energy X-ray absorptiometry (iDXA), “microscopic”
features of the optic nerve and macula, and brain magnetic resonance imaging
(MRI). During the assessment session, participants provided biological samples
(blood, saliva and urine) for analysis and storage. Part of the biological samples
were transferred to the diagnostic laboratories at Hamad General Hospital where
clinical diagnostic biomarkers were measured. The present study focused on 45
clinically-relevant traits as listed in Table 1, details of their measurements are
presented in Supplementary Data 1. All traits were normalized prior to the sta-
tistical analyses using rank-based inverse normal transformation using R ver. 3.4.0.
Whole genome sequencing. DNA was extracted from peripheral blood using the
automated QIASymphony SP instrument according to Qiagen MIDI kit protocol’s
recommendations (Qiagen, Germany). Genomic DNA integrity was assessed using
the Genomic DNA assay on the Caliper Labchip GXII (Perkin Elmer, USA). DNA
quantification was done using Quant-iT dsDNA Assay (Invitrogen, USA) on the
FlexStaion 3 (Molecular Devices, USA). Whole genome libraries were prepared
from 150 ng of DNA using the Illumina TruSeq DNA Nano kit. Genomic libraries
were sequenced on HiSeq X Ten (illumina, USA) following the manufacturer’s
recommended protocol to achieve a minimum average coverage of 30x. Library
construction and sequencing was performed at the Sidra Clinical Genomics
Laboratory Sequencing Facility. Quality control of Fastq files was performed using
FastQC (v0.11.2) (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/).
Reads were then aligned to GRCh37 (hs37d53) reference genome using bwa.kit
(v0.7.12) (https://github.com/lh3/bwa/tree/master/bwakit). Quality control on
mapped reads was performed using Picard (v1.117) [CollectWgsMetrics] (https://
gatk.broadinstitute.org/hc/en-us). Variant calling was performed following GATK
3.4 best practices (https://software.broadinstitute.org/gatk/documentation/article?
id=3238): Indel realignment and base recalibration was performed on the initial
bam file then HaplotypeCaller was run on each sample to generate an intermediate
genomic variant call file (gVCF). Joint variant calling was performed using all
generated gVCF files at once. We first run GenomicsDB8 to combine the different
samples by regions, then for each region, we ran GenotypeGVCFs, applied SNP/
Indel recalibration and then merged all regions.
The combined gVCF file contained 77,867,351 variants for 6218 subjects.
Quality control measures were applied to this file using PLINK ver. 2.019. Indels
and variants with MAF < 1%, genotype call rate < 90%, Hardy-WeinbergP value <
1 × 10−6, and those on chromosome X were removed leaving a total of 7,880,618
variants. We also removed samples with excess heterozygosity (N= 8), duplicates
(N= 10), call rate < 95% (N= 1), and gender ambiguity (N= 65). To identify
population ancestry outliers, we performed multidimensional scaling (mds)
analysis as implemented in PLINK19. Pairwise identity by-state (IBS) matrix was
determined based on a pruned set of independent autosomal SNPs (N= 62,475)
using a window size of 200 SNPS and LD threshold of r2= 0.05. Subjects with
more than four standard deviation units (±4 SD) away from the mean of the first
two mds components were identified as population outliers (N= 87) and removed
before analysis (Supplementary Fig. 5). The final file used for genome-wide
association analyses comprised 7,880,618 variants and 6047 subjects. Similar
quality control measures were applied to the replication dataset where we only
tested SNPs and traits showing evidence of novel associations from the
discovery set.
Heritability analysis. Heritability (h2) was defined as the proportion of phenotypic
variance attributed to genetic factors estimated from genome-wide SNP genotype
data. h2 was calculated using the polygenic model implemented in GenABEL ver.
1.8-020. The model included age, sex, and the first four principal components (PC)
as covariates. Genomic kinship matrix was used to correct for relatedness and was
determined using IBS analysis implemented in GenABEL. To enable comparison of
heritability with previously published work, we also calculated heritability using the
restricted maximum likelihood (GREML) method21 implemented in the software
package GCTA22. Age, sex, and the first four PCs were included as covariates in the
GREML model. Linear regression analysis was used to assess correlation between
heritability values across population ancestries.
Genome-wide association analysis. Genome wide association testing was per-
formed using the variance component-based method GRAMMAR-Gamma23
implemented in the R package GenABEL20. This model uses genomic kinship
matrix to correct for relatedness and genetic substructure. For all tested traits, we
included age, sex, and the first four PCs as covariates in the regression model.
Principal component analysis was performed using PLINK. Genome-wide sig-
nificance threshold was set as (P < 5 × 10−8)24. Regional association plots were
generated using the locusZoom tool25 using linkage disequilibrium data calculated
from QGP data using PLINK. Genomic inflation factor, Quantile-Quantile plots
and Manhattan plots were generated using R ver. 3.4.0.
Assessing genome-wide significant loci. We lumped all associations on a given
trait based on LD (r2 < 0.1) within a window size of 10 Mb into distinct signals
described by the SNP with the lowest p value. We annotated the SNPs representing
the distinct loci using PhenoScanner12 allowing for proxy SNPs reported in five
populations (AFR, AMR, EAS, EUR, SAS) using an LD cut-off of r2 > 0.1, a window
size of ±500 kb, and we used Experimental Factor Ontology (EFO) terms (https://
www.ebi.ac.uk/ols/ontologies/efo) to map phenotypes (Supplementary Data 3).
Any locus that did not produce a hit in PhenoScanner was further manually
checked using the GWAS catalog2 and PubMed literature searches (accessed on 31
January 2020).
Assessing replication of known loci. To assess the degree of replication of known
signals, we compared our results to previously published work focusing on a single
large GWAS of similar traits from the Biobank Japan project (BBJ)7. We dis-
tinguished three groups of SNPs in our comparisons to the BBJ study. Group A: an
identical SNP is present in the QGP population, Group B: a strong proxy SNP is
available for replication (r2 ≥ 0.8), group C: a SNP with LD (0.1 < r2 < 0.8) is
available. To identify any other signal, we also queried the region ±500 kb for
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association with the relevant trait. Correlation of effect size and allele frequency
was performed using linear regression analysis. To assess differences in associated
signals between QGP and BBJ we performed colocalization analysis using the Coloc
R-package ver. 3.2-126. We tested two hypotheses: H3; the locus is associated with
the trait in both BBJ and QGP but the association is driven by different variants,
H4; the locus is associated with the trait in both BBJ and QGP and the association
is driven by the same variants. Meta-analysis of discovery and replication results
was performed using the inverse variance-weighted method implemented in
METAL27.
Analysis of polygenic scores. Polygenic scores (PGS) scoring files were down-
loaded from the Polygenic Score catalog (http://www.pgscatalog.org) for traits with
available data. We selected PGS scores derived from the largest published study in
European populations. PGS were available for 11 traits from European populations
and details are presented in Supplementary Table 5. Weighted PGS were calculated
for each subject in QGP based on the scoring files using PLINK ver. 2.019. Pear-
son’s correlation (R) between the trait values and PGS were calculated using R.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
GWAS summary statistics generated in this study have been deposited in the NHGRI-
EBI Catalog of human genome-wide association studies and can be accessed through
[https://www.ebi.ac.uk/gwas/] under the accession codes GCST90013303,
GCST90013304, …, GCST90013347. All other data supporting the findings of this study
are available either within the article, the supplementary information and supplementary
data files, or from the authors upon reasonable request. The raw whole genome sequence
data are protected and are not available due to data privacy laws. Access to QBB/QGP
genotype and phenotype data can be obtained through an established ISO-certified
process by submitting a project request at [https://www.qatarbiobank.org.qa/research/
how-to-apply-new/] which is subject to approval by the QBB IRB committee. A detailed
description of the data management infrastructure for QBB was described previously28.
Data used in this study to assess replication of known loci are available in the NHGRI-
EBI Catalog of human genome-wide association studies [https://www.ebi.ac.uk/gwas/],
the Phenoscanner database [http://www.phenoscanner.medschl.cam.ac.uk], and the
Experimental Factor Ontology (EFO) terms database [https://www.ebi.ac.uk/ols/
ontologies/efo]. The Nhlh1 knockout mice data used in this study are available in the
international mouse phenotyping consortium database [https://www.mousephenotype.
org]. The polygenic scoring files used in this study are available in the Polygenic Score
Catalog [http://www.pgscatalog.org].
Code availability
The study utilized previously published analysis tools as described in the methods
section. No custom tools were used in this study.
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